GATEWAY INVESTMENT ADVISERS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1114618
CINCINNATI, OH
Position in REGN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$601,886
+$243,739 QoQ
Shares Held
779
+67.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GATEWAY INVESTMENT ADVISERS LLC holds $101,169,023 across 9 Biotechnology names. REGN ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
365,000 | $59,684,800 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,121 | $29,972,211 | |
| 3 | MRNA |
Moderna, Inc.
|
146,265 | $7,430,262 | |
| 4 | INCY |
Incyte Corp
|
18,024 | $1,696,418 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,251 | $744,788 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
779 | $601,886 | |
| 7 | TECH |
BIO-TECHNE Corp
|
9,712 | $507,549 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
1,474 | $278,659 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $601,886 | 779 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $358,147 | 464 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $250,210 | 445 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $321,300 | 612 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $586,662 | 925 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $578,411 | 812 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,170,030 | 1,113 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $995,325 | 947 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,286,849 | 1,337 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,032,869 | 1,176 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $721,735 | 877 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $657,464 | 915 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $799,484 | 973 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $722,211 | 1,001 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $626,871 | 910 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $574,578 | 972 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $664,197 | 951 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $697,198 | 1,104 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $682,643 | 1,128 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $643,996 | 1,153 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $571,079 | 1,207 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $563,789 | 1,167 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $671,736 | 1,200 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $805,755 | 1,292 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $626,964 | 1,284 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||